Literature DB >> 7723360

Racial differences in beta-adrenoceptor-mediated responsiveness.

J A Johnson1, B S Burlew, R N Stiles.   

Abstract

Previous studies have suggested that racial differences may exist in beta-adrenoceptor-mediated responsiveness. However, no clear conclusions can be drawn based on these studies because of the confounding effect of the parasympathetic nervous system on responses to isoproterenol bolus doses. In this study, we blocked the effects of the parasympathetic nervous system with atropine, to determine whether racial differences exist in sensitivity to beta-adrenoreceptor stimulation and blockade. Sixteen healthy black and white men participated in the study. Atropine was administered before all studies to induce parasympathetic blockade. Isoproterenol sensitivity studies and treadmill exercise were then performed in the with and without beta-adrenoceptor blockade by propranolol. Responses measured included heart rate (HR), blood pressure (BP), and tremor. The average isoproterenol dose producing a 25-beat/min increase in HR was more than twofold higher in blacks than in whites (3.4 +/- 1.2 vs. 1.6 +/- 0.4 micrograms, respectively, p < 0.05). There were no racial differences in response to beta-adrenoreceptor blockade. Our results showed that during parasympathetic blockade blacks were less sensitive to the chronotropic effects of isoproterenol than whites. We conclude that these response differences are due to greater beta-adrenoceptor sensitivity in whites than in blacks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7723360     DOI: 10.1097/00005344-199501000-00015

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  Beta blocker therapy in African American patients with heart failure.

Authors:  Sidney Goldstein
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

2.  Effect of propranolol on portal pressure and systemic hemodynamics in patients with liver cirrhosis and portal hypertension: a prospective study.

Authors:  Ki Tae Suk; Moon Young Kim; Dong Hun Park; Kyu Hong Kim; Ki Won Jo; Jin Hon Hong; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Soon Koo Baik
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

3.  Race and sex differences in cardiovascular α-adrenergic and β-adrenergic receptor responsiveness in men and women with high blood pressure.

Authors:  Andrew Sherwood; LaBarron K Hill; James A Blumenthal; Kristy S Johnson; Alan L Hinderliter
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

4.  Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Authors:  Daniel Kurnik; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mordechai Muszkat; Hong-Guang Xie; Paul A Harris; Scott M Williams; Usha B Nair; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

5.  Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts.

Authors:  T H Cheng; F Y Lee; J Wei; C I Lin
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

6.  Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Authors:  Tae Wan Kim; Hong Joo Kim; Chang Uk Chon; Hyun Sun Won; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Clin Mol Hepatol       Date:  2012-06-26

Review 7.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

8.  Efficacy of exercise for menopausal symptoms: a randomized controlled trial.

Authors:  Barbara Sternfeld; Katherine A Guthrie; Kristine E Ensrud; Andrea Z LaCroix; Joseph C Larson; Andrea L Dunn; Garnet L Anderson; Rebecca A Seguin; Janet S Carpenter; Katherine M Newton; Susan D Reed; Ellen W Freeman; Lee S Cohen; Hadine Joffe; Melanie Roberts; Bette J Caan
Journal:  Menopause       Date:  2014-04       Impact factor: 3.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.